3Zurcher M, Trainer M R, Walder B. Colonization and bloodstream infection with single-versus multi-lumen central venous catheters: a quantitative systematic re- view[J]. Anesth Analg, 2004,99 (1) : 177-182.
4Raad I. Intravascular-catheter-related infections[J]. Lan- cet, 1998,351 (9106) : 893-898.
5Jarvis W R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention[J]. Infect Control Hosp Epidemiol, 1996, 17 (8) :552-557.
6Pittet D, Tarara D, Wenzel R P. Nosoeomial bloodstream infection in critically ill patients. Excess length of stay,extra costs, and attributable mortality[J]. JAMA, 1994, 271 (20) : 1598-1601.
7Ferretti G, Mandala M, Di Cosimo S, et al. Catheter-re- lated bloodstream infections,part Ⅱ : specific pathogens and prevention[J]. Cancer Control, 2003,10(1) : 79-91.
8Merme L A, Farr B M, Sherertz R J, et al. Guidelines for the management of intravascular catheter related infec- tions[J]. J Intraven Nurs,2001,24(3) : 180-205.
9Monturo C A, Dickerson R N, Mullen J L. Effieaey of thrombolytic therapy for occlusion of long-term catheters [J]. JPEN J Parenter Enteral Nutr, 1990, 14 (3) : 312 -324.
10Trautner B W,Darouiche R O. Catheter-associated infec- tions: pathogenesis affects prevention[J]. Arch Intern Med, 2004,164 (8) : 842-850.
